These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 8539933)

  • 21. Anti-CD20 treatment prolongs syngeneic islet graft survival and delays the onset of recurrent autoimmune diabetes.
    Hu C; Deng S; Wong FS; Wen L
    Ann N Y Acad Sci; 2008 Dec; 1150():217-9. PubMed ID: 19120299
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Encapsulated islet iso-, allo-, and xenografts in diabetic NOD mice.
    Weber CJ; Hagler M; Konieczny B; Chryssochoos J; Rajotte R; Lakkis F; Lowry R
    Transplant Proc; 1995 Dec; 27(6):3308-11. PubMed ID: 8539965
    [No Abstract]   [Full Text] [Related]  

  • 23. Islet mass plays a critical role in initiation, but not progression, of the diabetogenic process in NOD mice.
    Kimura T; Ito A; Hancock WW; Maki T
    J Autoimmun; 1999 Jun; 12(4):243-9. PubMed ID: 10330295
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of cytokines during rejection of fetal pig islet xenografts in nonobese diabetic mice.
    Kovarik J; Faulkner-Jones BE; Koulmanda M; Mandel TE
    Transplant Proc; 1996 Apr; 28(2):811. PubMed ID: 8623411
    [No Abstract]   [Full Text] [Related]  

  • 25. Impact of donor immune cells in pancreatic islet transplantation.
    Carter JD; Chen M; Ellett JD; Smith KM; Nadler JL; Yang Z
    Transplant Proc; 2004 Nov; 36(9):2866-8. PubMed ID: 15621170
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Viral IL-10-mediated immune regulation in pancreatic islet transplantation.
    Carter JD; Ellett JD; Chen M; Smith KM; Fialkow LB; McDuffie MJ; Tung KS; Nadler JL; Yang Z
    Mol Ther; 2005 Aug; 12(2):360-8. PubMed ID: 16043104
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Linomide induces apoptotic death of cortical CD4/CD8 double positive thymocytes and thymic atrophy by a corticosteroid-independent pathway.
    Arbel I; Chezen E; Abramsky O; Karpati T; Ovadia H; Mizrachi-Koll R; Karussis D
    Clin Immunol; 1999 Jan; 90(1):108-14. PubMed ID: 9884358
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reversal of diabetes in non-obese diabetic mice without spleen cell-derived beta cell regeneration.
    Chong AS; Shen J; Tao J; Yin D; Kuznetsov A; Hara M; Philipson LH
    Science; 2006 Mar; 311(5768):1774-5. PubMed ID: 16556844
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Islet regeneration during the reversal of autoimmune diabetes in NOD mice.
    Kodama S; Kühtreiber W; Fujimura S; Dale EA; Faustman DL
    Science; 2003 Nov; 302(5648):1223-7. PubMed ID: 14615542
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Abrogation of recurrent autoimmunity in the NOD mouse: A critical role for host interleukin 4.
    Shi Q; Wang D; Hadley GA; Farber DL; Bartlett ST
    Surgery; 2006 Aug; 140(2):281-8. PubMed ID: 16904981
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term islet allograft survival in nonobese diabetic mice treated with tacrolimus, rapamycin, and anti-interleukin-2 antibody.
    Molano RD; Pileggi A; Berney T; Poggioli R; Zahr E; Oliver R; Malek TR; Ricordi C; Inverardi L
    Transplantation; 2003 Jun; 75(11):1812-9. PubMed ID: 12811239
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IL-4 prevents insulitis and insulin-dependent diabetes mellitus in nonobese diabetic mice by potentiation of regulatory T helper-2 cell function.
    Cameron MJ; Arreaza GA; Zucker P; Chensue SW; Strieter RM; Chakrabarti S; Delovitch TL
    J Immunol; 1997 Nov; 159(10):4686-92. PubMed ID: 9366391
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhancement of Th2 responses to replicative herpes simplex virus type 1 vectors by immunomodulative chemotherapy.
    Peltoniemi J; Broberg EK; Nygårdas M; Erälinna JP; Waris M; Hukkanen V
    Int Immunopharmacol; 2006 May; 6(5):817-29. PubMed ID: 16546713
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combination therapy with low dose sirolimus and tacrolimus is synergistic in preventing spontaneous and recurrent autoimmune diabetes in non-obese diabetic mice.
    Shapiro AM; Suarez-Pinzon WL; Power R; Rabinovitch A
    Diabetologia; 2002 Feb; 45(2):224-30. PubMed ID: 11935154
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diabetes results from a late change in the autoimmune response of NOD mice.
    Gazda LS; Charlton B; Lafferty KJ
    J Autoimmun; 1997 Jun; 10(3):261-70. PubMed ID: 9218753
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunological reversal of autoimmune diabetes without hematopoietic replacement of beta cells.
    Suri A; Calderon B; Esparza TJ; Frederick K; Bittner P; Unanue ER
    Science; 2006 Mar; 311(5768):1778-80. PubMed ID: 16556846
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolically inactive insulin analog prevents type I diabetes in prediabetic NOD mice.
    Karounos DG; Bryson JS; Cohen DA
    J Clin Invest; 1997 Sep; 100(6):1344-8. PubMed ID: 9294099
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Indefinite islet protection from autoimmune destruction in nonobese diabetic mice by agarose microencapsulation without immunosuppression.
    Kobayashi T; Aomatsu Y; Iwata H; Kin T; Kanehiro H; Hisanaga M; Ko S; Nagao M; Nakajima Y
    Transplantation; 2003 Mar; 75(5):619-25. PubMed ID: 12640299
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduced incidence of diabetes in nonobese diabetic mice transplanted with thymus from diabetes-resistant donors.
    Georgiou HM; Mandel TE
    Transplant Proc; 1992 Feb; 24(1):203-4. PubMed ID: 1539248
    [No Abstract]   [Full Text] [Related]  

  • 40. Islet recovery and reversal of murine type 1 diabetes in the absence of any infused spleen cell contribution.
    Nishio J; Gaglia JL; Turvey SE; Campbell C; Benoist C; Mathis D
    Science; 2006 Mar; 311(5768):1775-8. PubMed ID: 16556845
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.